| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 01/25/2007 | US20070020176 Contrast agent |
| 01/25/2007 | US20070018155 New imidazole derivatives, preparation method thereof and organic electronic device using the same |
| 01/25/2007 | US20070018154 Imidazole derivatives and organic electronic device using the same |
| 01/25/2007 | CA2616063A1 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives as v1a receptor antagonists |
| 01/25/2007 | CA2615751A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 01/25/2007 | CA2615403A1 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/25/2007 | CA2615380A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | CA2615373A1 Quinazoline derivatives useful in cancer treatment |
| 01/25/2007 | CA2615238A1 Preparation of terazole derivatives |
| 01/25/2007 | CA2612469A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 01/25/2007 | CA2612468A1 4,5-dihydr0-1h-pyrazole derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2611366A1 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/25/2007 | CA2611364A1 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 01/24/2007 | EP1746093A1 Process for preparing substituted pyrimidines |
| 01/24/2007 | EP1746090A1 Sustituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood |
| 01/24/2007 | EP1746087A1 Derivates of 3-indolylmethylene having cytostatic properties |
| 01/24/2007 | EP1745041A2 Quinoxaline inhibitors of the hedgehog signalling pathway |
| 01/24/2007 | EP1745040A1 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 01/24/2007 | EP1745039A2 3-aryl-5,6-disubstituted pyridazines |
| 01/24/2007 | EP1745038A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 01/24/2007 | EP1745037A1 Indolylmaleimide derivatives as pkc inhibitors |
| 01/24/2007 | EP1745034A1 Vanilloid receptor ligands and their use in treatments |
| 01/24/2007 | EP1745033A2 4,5-disubstituted-2-aryl pyrimidines |
| 01/24/2007 | EP1745021A1 Hydroformylation process for pharmaceutical intermediate |
| 01/24/2007 | EP1745019A1 Novel compounds of proline and morpholine derivatives |
| 01/24/2007 | EP1322710B1 Modified carbocyanine dyes and their conjugates |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | CN1902195A Modulators of cellular adhesion |
| 01/24/2007 | CN1902193A Quinoxalines useful as inhibitors of protein kinases |
| 01/24/2007 | CN1902192A Preparation of candesartan cilexetil |
| 01/24/2007 | CN1902181A Benzimidazoles useful as modulators of ion channels |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1902168A Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1901917A (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 01/24/2007 | CN1901916A Quinazolinone compounds with reduced bioaccumulation |
| 01/24/2007 | CN1296369C Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate |
| 01/24/2007 | CN1296354C Pharmaceutically active pyrrolidine derivatives as BAX inhibitors |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166659 Substituted 5-aryl-2-(2-hydroxyphenyl)-2H-benzotriazole UV absorbers, compositions stabilized therewith and process for preparation thereof |
| 01/23/2007 | US7166634 Bis-indole pyrroles useful as antimicrobials agents |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166628 Inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds. Ar1 is carbocycle optionally substituted with one R1, and wherein Ar1 |
| 01/23/2007 | US7166615 Substituted indolinones, preparation thereof and their use as pharmaceutical compositions |
| 01/23/2007 | US7166609 Osteoarthritis; periodontal disease; antiarthritic agents |
| 01/23/2007 | US7166607 Substituted indoles |
| 01/23/2007 | US7166604 N-Heterocyclic derivatives; picornavirus infections in mammals; human rhinovirus |
| 01/23/2007 | US7166603 Dihydropyrimidone inhibitors of calcium channel function |
| 01/23/2007 | US7166599 Trisubstituted pyrimidines |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166595 3H-Pyrimidin-4-one derivatives; antiproliferative, anticarcinogenic and antiinflammatory agents; hyperplasia, restenosis, cardiac hypertrophy, autoimmune disorders; fungicides |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166368 A platinum complexes containing a 2,4-pentanedionate group and pyridyl group, maxima spectral emittance |
| 01/23/2007 | CA2206754C Benzimidazole derivatives with antihistaminic activity |
| 01/18/2007 | WO2007008985A2 Kinase inhibitors |
| 01/18/2007 | WO2007008895A1 Kinase inhibitors |
| 01/18/2007 | WO2007008664A1 3-spir0cycl0pr0pyl2-0xind0le kinase inhibitors |
| 01/18/2007 | WO2007008588A2 Omeprazole form b |
| 01/18/2007 | WO2007008145A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008144A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007008143A1 Heterocyclic sulfonamide derivatives as inhibitors of factor xa |
| 01/18/2007 | WO2007007886A1 An oxime derivative and preparations thereof |
| 01/18/2007 | WO2007007778A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007054A1 Phthalamides, succinimides and related compounds and their use as pharmaceuticals |
| 01/18/2007 | WO2007007042A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007007041A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007006928A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 01/18/2007 | WO2007006739A1 Benzoheterocyclylethylcarboxamide derivatives |
| 01/18/2007 | WO2007006677A1 Benzimidazole derivatives as 5-ht6,5-ht24 |
| 01/18/2007 | WO2007006534A2 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 01/18/2007 | WO2007006533A2 Indolylmaleimide derivatives |
| 01/18/2007 | WO2006113140A3 Novel compounds useful for bradykinin b1 receptor antagonism |
| 01/18/2007 | WO2006096709B1 Process for preparing amorphous salts |
| 01/18/2007 | US20070015912 Azo compound and tautomer thereof |
| 01/18/2007 | US20070015816 Antibody specific for 4-methyl-3-vinylmaleimide derivatives; photolabile degradation product of bilirubin or biliverdin; antiinflammatory agents, infections,systemic inflammatory response syndrome |
| 01/18/2007 | US20070015811 5(S)-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments |
| 01/18/2007 | US20070015810 5(R)-Substituted Pyrazoline Compounds, their Preparation and Use as Medicaments |
| 01/18/2007 | US20070015807 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
| 01/18/2007 | US20070015792 Having at the 1-position a {spiro[4.5]dec-6-yl, spiro[2.5]oct-4-yl, spiro[3.5]non-5-yl, bicyclo[2.2.1]hept-2-yl, or 1-spiro(bicyclo[2.2.1]heptane-2,1'-cyclopropan)-3-yl} methyl group; nociceptin receptor Opioid receptor-like-1 receptor antagonists; analgesics, antidepressants; neurodegenerative diseases |
| 01/18/2007 | US20070015779 [1-(4-pyrimidinyl, 5-pyrrolyl, or 4-pyridinyl)-3,5-disubstituted-1H-pyrazol-4-yl]dihydroxyalkanoic acids and 6-alkyl-gamma-hydroxyvalerolactones; antiinflammatory agents; carciovascular disorders; p38 map kinase inhibitors |
| 01/18/2007 | US20070015774 Quinazoline derivatives useful in cancer treatment |
| 01/18/2007 | US20070015773 Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disorders |
| 01/18/2007 | US20070015767 treating with hot water; pancreatic and prostate cancer |
| 01/18/2007 | US20070015766 Quinoline Derivatives as NK-3 and NK-2 Antagonists |
| 01/18/2007 | US20070015758 Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 01/18/2007 | US20070015756 For therapy of hyperproliferative diseases |
| 01/18/2007 | US20070015752 Biaryl compositions and methods for modulating a kinase cascade |
| 01/18/2007 | US20070015748 Kinase Inhibitors |
| 01/18/2007 | US20070015747 Respiratory syncytial virus replication inhibitors |
| 01/18/2007 | US20070015743 Quinazoline derivatives as antitumor agents |
| 01/18/2007 | CA2615007A1 Benzimidazole derivatives as 5-ht6,5-ht24 |
| 01/18/2007 | CA2614691A1 Piperidine derivatives useful in the diagnostic and therapeutic treatment of diseases depending on renin activity |
| 01/18/2007 | CA2614597A1 Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as ikk inhibitors |
| 01/18/2007 | CA2614147A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 01/18/2007 | CA2612442A1 Heterotetracyclic compounds as tpo mimetics |
| 01/18/2007 | CA2611607A1 Indolylmaleimide derivatives |
| 01/18/2007 | CA2603115A1 3-spirocyclopropyl2-oxindole kinase inhibitors |
| 01/18/2007 | CA2602453A1 Kinase inhibitors |
| 01/18/2007 | CA2602389A1 Kinase inhibitors |